Marrubenol inhibits contraction of rat arteries by blocking L-type calcium (Ca
2+) channels in smooth muscle cells, but its interaction with binding sites for calcium antagonists had never been investigated. Competition binding studies indicated that marrubenol was a weak inhibitor of 1,4-dihydropyridine binding in membranes isolated from rat intestinal smooth muscle but completely displaced specifically bound (−)-[
3H]desmethoxyverapamil ([
3H]D888) with an apparent
Ki value of 16 μM (95 % confidence interval: 6.5–39.5 μM). As marrubenol inhibited the contraction evoked by KCl depolarization of intestinal smooth muscle half-maximally at a concentration of
12 μM, interaction with the phenylalkylamine binding site seems to account for the inhibition of L-type Ca
2+ channels by marrubenol.